Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SNCAIP contributors: mct - updated : 02-10-2013
HGNC name synuclein, alpha interacting protein (synphilin)
HGNC id 11139
Corresponding disease
PARK25 Parkinson disease 25
Location 5q23.2      Physical location : 121.647.819 - 121.799.794
Synonym name synphilin 1
Synonym symbol(s) SYPH1, SPH1
DNA
TYPE functioning gene
STRUCTURE 151.97 kb     11 Exon(s)
10 Kb 5' upstream gene genomic sequence study
motif repetitive sequence
text structure GT repeat polymorphic
MAPPING cloned Y linked N status confirmed
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
11 - 3569 - 919 - 2004 15322916
  • synphilin
  • 10 - 2588 - 603 present in Lewy bodies of Parkinson's disease and Diffuse Lewy Body disease 2004 15322916
  • synphilin-1A
  • having enhanced aggregatory properties and causing neurotoxicity
  • binding to alpha-synuclein and inducing dopaminergic cells
  • overexpression in neurons results in striking cellular toxicity attenuated by the formation of synphilin-1A inclusions, which recruit alpha-synuclein
  • contributing to neuronal degeneration in alpha-synucleinopathies and providing important insights into the role of inclusion bodies in neurodegenerative disorders
  • inhibits SIAH and modulates SNCA monoubiquitylation and inclusion formation (Szargel 2009)
  • EXPRESSION
    Type ubiquitous
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Cardiovascularheart   highly
    Digestivemouth   highly
    Hearing/Equilibriumearinnercochlea highly
    Nervousbrain   highly
    Reproductivemale systemtestis  moderately
    Respiratorylung   moderately
     respiratory tractlarynx  highly
     respiratory tracttrachea  moderately
    tissue
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Connective   lowly
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    physiological period pregnancy
    Text placenta highly
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • a central domain
  • six ankyrin-like (ANK) repeats
  • a central coiled-coil domain that specifically interacts with the N-terminal stretch of SNCA
  • an ATP/GTP binding domain
  • a protein-protein interaction domain
  • HOMOLOGY
    interspecies homolog to rattus Sncaip (86.18 pc)
    homolog to murine Sncaip (86.97 pc)
    Homologene
    FAMILY
    CATEGORY structural protein
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm
    intracellular,nucleus,nucleolus
    text neuropil
    basic FUNCTION
  • promoting formation of cytosolic inclusions in neurons
  • protecting the neurons against cellular stress
  • synaptic partner of SNCA, may be mediating synaptic roles attributed to SNCA
  • role in synaptic function and protein degradation and in the molecular mechanisms leading to neurodegeneration in Parkinson disease
  • SNCAIP inhibition of the proteasomal pathway of degradation of SNCA may help to understand the pathophysiological changes occurring in Parkinson disease and other synucleinopathies
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • binding to SNCA and PARK2 in neurons
  • interacting with PSMC4
  • interacting with the E3 ubiquitin -ligase SIAH1 and SIAH2
  • ubiquitylated by RNF19 in Parkinson disease
  • ubiquitination by parkin may be involved in the formation of Lewy body inclusions associated with Parkinson disease
  • PPHLN1 is a novel interactor of SNCAIP
  • the specific interaction between SNCA and SNCAIP provides mechanistic insights into the inclusion-body formation in cells and pathological implication in Parkinson disease
  • interacts with alpha-synuclein (SNCA), promoting its aggregation
  • NUB1 is a SNCAIP-binding protein, also accumulating in Lewy bodies
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) PARK25
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional germinal mutation      
    in Parkinson disease (component of Lewy bodies in brain)
    constitutional     --over  
    and accumulated in brain lesions in which SNCA is a major component
    tumoral somatic mutation      
    SNCAIP duplication is a somatic event highly specific to Group 4 medulloblastoma
    Susceptibility
    Variant & Polymorphism other R621C mutation increase the risk of Parkinson disease
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS